Typhim VI 25 MCG/0.5 ML syrng 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F20UL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,021
Award facts
- Contract value 100% obligated
- $15,021.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerSourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $15,021.30 by the Defense Logistics Agency (DLA) on January 15, 2026, for the supply of TYPHIM VI 25 MCG/0.5 ML syringe vaccine. The contract carries a firm fixed-price structure with no set-aside designation, indicating it was competitively awarded on a full and open basis. Performance is scheduled for completion by January 16, 2026, with work to be performed at the contractor's Conshohocken facility. This delivery order was issued under AmerSourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive $999,999,999.00 global pharmaceutical support vehicle running through December 2026.
The DLA Medical Supply Chain utilizes such delivery orders to procure critical medical commodities, including vaccines and specialty medications, in support of military healthcare programs worldwide. AmerSourceBergen's parent company, Cencora, Inc. (doing business as AmerSourceBergen), maintains a substantial indefinite delivery contract with DLA valued at up to $999,999,999.00 through December 2031, positioning the company as a key vendor for federal medical procurement. The TYPHIM VI vaccine delivery under this order supports the Defense Health Agency and broader military healthcare requirements, demonstrating the contractor's role in supplying essential immunization products to the Department of Defense.
Quick answers
Who was awarded contract SPE2DR26F20UL?
SPE2DR26F20UL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F20UL worth?
The government has obligated $15,021 on SPE2DR26F20UL.
Is contract SPE2DR26F20UL an order under another contract?
Yes. SPE2DR26F20UL is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F20UL competed?
The extent of competition for SPE2DR26F20UL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award